Quantification of the immunohistochemical staining of fibroblast activation protein in intrathoracic solitary fibrous tumors using QuPath
Purpose Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, whic...
Saved in:
Published in | Surgery today (Tokyo, Japan) Vol. 55; no. 9; pp. 1269 - 1273 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Springer Nature Singapore
01.09.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 0941-1291 1436-2813 1436-2813 |
DOI | 10.1007/s00595-025-03024-y |
Cover
Loading…
Abstract | Purpose
Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs.
Methods
The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath.
Results
Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP.
Conclusion
Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules. |
---|---|
AbstractList | Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs.PURPOSESolitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs.The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath.METHODSThe subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath.Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP.RESULTSImmunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP.Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules.CONCLUSIONOur results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules. Purpose Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs. Methods The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath. Results Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP. Conclusion Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules. Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs. The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath. Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP. Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules. |
Author | Kimura, Toru Maniwa, Tomohiro Shintani, Yasushi Watabe, Tadashi Honma, Keiichiro Omura, Akiisa Okami, Jiro |
Author_xml | – sequence: 1 givenname: Akiisa surname: Omura fullname: Omura, Akiisa organization: Department of General Thoracic Surgery, Osaka International Cancer Institute, Department of General Thoracic Surgery, Osaka University Graduate School of Medicine – sequence: 2 givenname: Toru surname: Kimura fullname: Kimura, Toru email: kimura@thoracic.med.osaka-u.ac.jp organization: Department of General Thoracic Surgery, Osaka International Cancer Institute, Department of General Thoracic Surgery, Osaka University Graduate School of Medicine – sequence: 3 givenname: Tomohiro surname: Maniwa fullname: Maniwa, Tomohiro organization: Department of General Thoracic Surgery, Osaka International Cancer Institute – sequence: 4 givenname: Tadashi surname: Watabe fullname: Watabe, Tadashi organization: Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine – sequence: 5 givenname: Keiichiro surname: Honma fullname: Honma, Keiichiro organization: Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute – sequence: 6 givenname: Yasushi surname: Shintani fullname: Shintani, Yasushi organization: Department of General Thoracic Surgery, Osaka University Graduate School of Medicine – sequence: 7 givenname: Jiro surname: Okami fullname: Okami, Jiro organization: Department of General Thoracic Surgery, Osaka International Cancer Institute |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40126602$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1q3DAUhUVJaSZpX6CLomU3bq_-bHlVSugfBNJAshayRhor2NJUkgPzCH3rauI0tJuAhBb3O-feq3OGTkIMFqG3BD4QgO5jBhC9aIDWy4Dy5vACbQhnbUMlYSdoAz0nDaE9OUVnOd9BZSTAK3TKgdC2BbpBv68XHYp33ujiY8DR4TJa7Od5CXH0uUQz2rlWJ5yL9sGH3ZFxfkhxmHQuWJvi71fxPsVifcAPpyRdxpi08QbnOPmi02HVLRmXZY4p4yUf_a6XnxV9jV46PWX75vE9R7dfv9xcfG8ur779uPh82RjOeWkItI51tBVgBKVSs9bJlg2d6G0HxDHJad8J1zEQneNdO2xFP2wHZzTrhWwJO0efVt_9Msx2a-xx0kntk5_rhCpqr_6vBD-qXbxXhDIJfQ_V4f2jQ4q_FpuLmn02dpp0sHU5xUjlJCeSVfTdv82euvwNoAJ0BUyKOSfrnhAC6piyWlNWNWX1kLI6VBFbRbnCYWeTuotLCvXXnlP9ATRtrmc |
Cites_doi | 10.2967/jnumed.123.266393 10.1007/s00259-022-06052-9 10.1186/s13019-023-02168-7 10.1002/prca.201300095 10.2967/jnumed.123.266411 10.1097/JTO.0b013e3182653d64 10.1038/modpathol.2013.164 10.2967/jnumed.123.265481 10.1016/j.cpet.2023.02.007 10.1016/j.urology.2019.01.029 10.1007/s00330-023-10013-7 10.3892/ol.2022.13375 10.1158/1078-0432.CCR-19-2238 10.1186/s13000-021-01095-2 10.2967/jnumed.123.265486 10.3390/ijms24032746 10.1016/S0003-4975(01)03374-4 10.1016/j.prp.2024.155380 10.2967/jnumed.122.264544 10.1016/j.annonc.2024.08.712 10.1038/s41598-017-17204-5 10.1097/RLU.0000000000003598 10.1155/2023/2480493 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1007/s00595-025-03024-y |
DatabaseName | SpringerOpen CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1436-2813 |
EndPage | 1273 |
ExternalDocumentID | PMC12380990 40126602 10_1007_s00595_025_03024_y |
Genre | Journal Article |
GrantInformation_xml | – fundername: Japan Society for the Promotion of Science grantid: JP22K09014 funderid: http://dx.doi.org/10.13039/501100001691 – fundername: Osaka University – fundername: Japan Society for the Promotion of Science grantid: JP22K09014 |
GroupedDBID | --- -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 123 1SB 2.D 203 28- 29Q 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2WC 2~H 30V 3O- 4.4 406 408 409 40D 40E 53G 5QI 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSTC ACUDM ACZOJ ADHHG ADHIR ADHKG ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFHIU AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AXYYD AYFIA AZFZN B-. BA0 BBWZM BDATZ BGNMA BSONS C6C CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PT4 PT5 QOK QOR QOS R89 R9I RHV RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 ZMTXR ZOVNA ~A9 ~EX AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c444t-106f372650c5228a36f863b759e701f3842975f73057f476bd59bdbfca3958613 |
IEDL.DBID | U2A |
ISSN | 0941-1291 1436-2813 |
IngestDate | Fri Aug 29 05:29:37 EDT 2025 Fri Sep 05 06:10:53 EDT 2025 Wed Sep 03 02:27:45 EDT 2025 Wed Aug 27 16:41:28 EDT 2025 Wed Aug 27 01:34:09 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Pleural tumor Malignant potential Solitary fibrous tumor Fibroblast activation protein Diagnostic target |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c444t-106f372650c5228a36f863b759e701f3842975f73057f476bd59bdbfca3958613 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://link.springer.com/10.1007/s00595-025-03024-y |
PMID | 40126602 |
PQID | 3180984183 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12380990 proquest_miscellaneous_3180984183 pubmed_primary_40126602 crossref_primary_10_1007_s00595_025_03024_y springer_journals_10_1007_s00595_025_03024_y |
PublicationCentury | 2000 |
PublicationDate | 20250900 |
PublicationDateYYYYMMDD | 2025-09-01 |
PublicationDate_xml | – month: 9 year: 2025 text: 20250900 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore – name: Japan |
PublicationSubtitle | Official Journal of the Japan Surgical Society |
PublicationTitle | Surgery today (Tokyo, Japan) |
PublicationTitleAbbrev | Surg Today |
PublicationTitleAlternate | Surg Today |
PublicationYear | 2025 |
Publisher | Springer Nature Singapore |
Publisher_xml | – name: Springer Nature Singapore |
References | T Watabe (3024_CR5) 2023; 64 M de Perrot (3024_CR14) 2002; 74 H Ajouz (3024_CR17) 2023; 18 T Kimura (3024_CR11) 2024; 259 F Lococo (3024_CR15) 2012; 7 F Lococo (3024_CR16) 2014; 33 P Rasinski (3024_CR23) 2023; 64 Q Zheng (3024_CR13) 2023; 24 LA Doyle (3024_CR19) 2014; 27 Q Yang (3024_CR24) 2024; 34 A Zhang (3024_CR25) 2021; 46 CJ Twelves (3024_CR9) 2024; 35 R Hamacher (3024_CR10) 2024; 65 Y Pang (3024_CR22) 2023; 64 S Sammoud (3024_CR3) 2019; 127 M Fabre (3024_CR8) 2020; 26 P Bankhead (3024_CR12) 2017; 7 Q Li (3024_CR2) 2022; 24 Y Mori (3024_CR7) 2023; 18 W Li (3024_CR21) 2023; 13 MU Tariq (3024_CR1) 2021; 16 JN Crane (3024_CR18) 2023; 2023 AF van den Hoven (3024_CR6) 2023; 50 AM Spektor (3024_CR20) 2024; 65 EJ Hamson (3024_CR4) 2014; 8 |
References_xml | – volume: 65 start-page: 52 year: 2024 ident: 3024_CR20 publication-title: J Nucl Med doi: 10.2967/jnumed.123.266393 – volume: 50 start-page: 1014 year: 2023 ident: 3024_CR6 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-022-06052-9 – volume: 18 start-page: 79 year: 2023 ident: 3024_CR17 publication-title: J Cardiothorac Surg doi: 10.1186/s13019-023-02168-7 – volume: 8 start-page: 454 year: 2014 ident: 3024_CR4 publication-title: Proteomics Clin Appl doi: 10.1002/prca.201300095 – volume: 65 start-page: 252 year: 2024 ident: 3024_CR10 publication-title: J Nucl Med doi: 10.2967/jnumed.123.266411 – volume: 7 start-page: 1698 year: 2012 ident: 3024_CR15 publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e3182653d64 – volume: 27 start-page: 390 year: 2014 ident: 3024_CR19 publication-title: Mod Pathol doi: 10.1038/modpathol.2013.164 – volume: 64 start-page: 1232 year: 2023 ident: 3024_CR23 publication-title: J Nucl Med doi: 10.2967/jnumed.123.265481 – volume: 18 start-page: 419 year: 2023 ident: 3024_CR7 publication-title: PET Clin doi: 10.1016/j.cpet.2023.02.007 – volume: 127 start-page: 9 year: 2019 ident: 3024_CR3 publication-title: Urology doi: 10.1016/j.urology.2019.01.029 – volume: 34 start-page: 1077 year: 2024 ident: 3024_CR24 publication-title: Eur Radiol doi: 10.1007/s00330-023-10013-7 – volume: 24 start-page: 255 issue: 2 year: 2022 ident: 3024_CR2 publication-title: Oncol Lett doi: 10.3892/ol.2022.13375 – volume: 26 start-page: 3420 year: 2020 ident: 3024_CR8 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-19-2238 – volume: 16 start-page: 32 year: 2021 ident: 3024_CR1 publication-title: Diagn Pathol doi: 10.1186/s13000-021-01095-2 – volume: 13 start-page: 4547 year: 2023 ident: 3024_CR21 publication-title: Am J Cancer Res – volume: 33 start-page: 109 year: 2014 ident: 3024_CR16 publication-title: Rev Esp Med Nucl Imagen Mol – volume: 64 start-page: 1225 year: 2023 ident: 3024_CR5 publication-title: J Nucl Med doi: 10.2967/jnumed.123.265486 – volume: 24 start-page: 2746 year: 2023 ident: 3024_CR13 publication-title: Int J Mol Sci doi: 10.3390/ijms24032746 – volume: 74 start-page: 285 year: 2002 ident: 3024_CR14 publication-title: Ann Thorac Surg doi: 10.1016/S0003-4975(01)03374-4 – volume: 259 year: 2024 ident: 3024_CR11 publication-title: Pathol Res Pract doi: 10.1016/j.prp.2024.155380 – volume: 64 start-page: 386 year: 2023 ident: 3024_CR22 publication-title: Prospective Study J Nucl Med doi: 10.2967/jnumed.122.264544 – volume: 35 start-page: S511 year: 2024 ident: 3024_CR9 publication-title: Ann Oncol doi: 10.1016/j.annonc.2024.08.712 – volume: 7 start-page: 16878 year: 2017 ident: 3024_CR12 publication-title: Sci Rep doi: 10.1038/s41598-017-17204-5 – volume: 46 start-page: e534 year: 2021 ident: 3024_CR25 publication-title: Clin Nucl Med doi: 10.1097/RLU.0000000000003598 – volume: 2023 start-page: 2480493 year: 2023 ident: 3024_CR18 publication-title: Sarcoma doi: 10.1155/2023/2480493 |
SSID | ssj0024800 |
Score | 2.4048834 |
Snippet | Purpose
Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have... Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1269 |
SubjectTerms | Adult Aged Biomarkers, Tumor - analysis Biomarkers, Tumor - metabolism Endopeptidases Female Gelatinases - analysis Gelatinases - metabolism Humans Immunohistochemistry - methods Lung Neoplasms - diagnosis Lung Neoplasms - secondary Male Medicine Medicine & Public Health Membrane Proteins - analysis Membrane Proteins - metabolism Middle Aged Original Original Article Retrospective Studies Serine Endopeptidases - analysis Serine Endopeptidases - metabolism Solitary Fibrous Tumors - diagnosis Solitary Fibrous Tumors - metabolism Solitary Fibrous Tumors - pathology Solitary Fibrous Tumors - surgery Surgery Surgical Oncology Thoracic Neoplasms - diagnosis Thoracic Neoplasms - pathology |
Title | Quantification of the immunohistochemical staining of fibroblast activation protein in intrathoracic solitary fibrous tumors using QuPath |
URI | https://link.springer.com/article/10.1007/s00595-025-03024-y https://www.ncbi.nlm.nih.gov/pubmed/40126602 https://www.proquest.com/docview/3180984183 https://pubmed.ncbi.nlm.nih.gov/PMC12380990 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1da9swFL2sLYy9jH118z6CBntrDYklWfJjGpqVjZUVGmifjKRYbR5qj9h-yE_Yv969sp2RtRQGNn6w7Ng-su5R7j3HAF-EUkZJm8VLwV0sPL1SGJniSebGQhWcDFuo2uI8PVuIb1fyqheF1UO1-5CSDCP1VuxGOklSE-PKMbLEmz04kDh3p0K-RTL967CnO-FJJiYxRrNJL5V5-By74egex7xfKvlPvjSEofkLeN7zRzbtAH8JT4ryFTz90WfIX8Pvi9Z09T_hkbPKM6R4bEUykCqYC7veIoAF5RT-CLXxOGuuLDLphpHSofuflgUTh1XJwkI2trfYYdzKsZqq5sx60x3X1qxp76p1zaiK_oZdtD-x6RtYzE8vZ2dx_7mF2AkhGhyQU89VgpTNISnThqdep9wqmRVqPEEUBalwPQ4JUnmhUruUmV1a7wzPpEZacAj7ZVUW74B5hdAn1nFlcP5pkkw7La3x0ogsUdJFcDQ89fxX56qRb_2TA0Y5YpQHjPJNBJ8HYHLs_JTRMGWBN5dzch_TAoelCN52QG3PhxNHJB_jJAK9A-G2ARlr7-4pV7fBYBujuaaEYQTHA9p5_2rXj1zn-_9r_gGeJaEnUsHaR9hv1m3xCRlOY0dwMJ2fnJzT9uv199MR7M3S2Sh08z9nU_no |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB3BVoJeCgXapnzUSNwg1W5sx86xQi0L_RCVulI5WbY3pivUpNokh-Uf8K87dpJF2yKkSskpTrK2xzPPO_NeAD4wIbTgJounjNqYOb-kMDLFo8wOmcipF2zx1RZn6XjCvl3yy44UVvXV7n1KMnjqJdnN8yQ9mxhPipElXjyGNYZ7cDaAtYMvP44P_2rsyZZ6krFRjPFs1JFl_v2U1YB0D2XeL5a8kzENgejoGUz6LrT1J7_2m9rs29931B0f2sfnsNEhU3LQmtImPMqLF_DktMu9v4Q_541uK4vCZJLSEQSPZOYJJmWQLbad-AAJnCx8r2_jcD9eGsToNfEcivYfYBLkIWYFCYcXyL1CU7QzSypfj6fni_a-piJ1c13OK-Lr83-S8-Y7Nn0Fk6PDi8_juPuQQ2wZYzW6-tRRkSAYtAj3pKapkyk1gme5GI7QPpjn9zp0Nlw4JlIz5ZmZGmc1zbhEwLEFg6Is8h0gTqBRJcZSoXFnq5NMWsmNdlyzLBHcRvCxn0110-p1qKUycxhdhaOrwuiqRQTv-wlXuKx8rkQXOXZOUa9rJhk6vAi2WwNYPg-3pAhrhkkEcsU0lg28ZPfqlWJ2FaS7ESdIn4qM4FNvAKpzGtV_fufuw5rvwdPxxemJOvl6dvwa1pNgT74s7g0M6nmTv0UcVZt33bK5BQ1WFjE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVqq4lDcNTyNxg7S7iR07x6rtUihUrUSlcopsb0xXVZNqNzks_4B_zYydLGyLkBBScopj-TH2fM7M9wXgDZdSS2HyeMJTG3NHSwo9UzzK7ZDLMiXBFsq2OMoOTvnHM3H2G4vfZ7v3IcnAaSCVpqrZvpq47SXxjTiTxCzGO0UvEy9uwxoncfYBrO28_3q4_0tvTwUaSs5HMfq2UUec-XMtq87pBuK8mTh5LXrqndL4Lui-OyEX5WKrbcyW_X5N6fF_-nsPNjrEynaCid2HW2X1ANY_dzH5h_DjpNUh48hPMqsdQ1DJpkQ8qb2cse1ECZjnamEbqIzDc3ptELs3jLgV4csw87IR04r5i4Rzz9FE7dSyOeXp6dkivNfOWdNe1rM5o7z9b-ykPcaij-B0vP9l9yDufvAQW855gy4gc6lMECRahIFKp5lTWWqkyEs5HKHdcOL9OtyEhHRcZmYicjMxzuo0FwqByGMYVHVVbgJzEo0tMTaVGk-8OsmVVcJoJzTPEylsBG_7mS2ugo5HsVRs9qNb4OgWfnSLRQSv-8kvcLlRDEVXJXauSEnvTHHcCCN4EoxhWR8eVRHuDJMI1IqZLAuQlPfqk2p67iW9ET8oClFG8K43hqLbTOZ_aefTfyv-CtaP98bFpw9Hh8_gTuLNibLlnsOgmbXlC4RXjXnZraCfXWofFQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+the+immunohistochemical+staining+of+fibroblast+activation+protein+in+intrathoracic+solitary+fibrous+tumors+using+QuPath&rft.jtitle=Surgery+today+%28Tokyo%2C+Japan%29&rft.au=Omura%2C+Akiisa&rft.au=Kimura%2C+Toru&rft.au=Maniwa%2C+Tomohiro&rft.au=Watabe%2C+Tadashi&rft.date=2025-09-01&rft.eissn=1436-2813&rft.volume=55&rft.issue=9&rft.spage=1269&rft_id=info:doi/10.1007%2Fs00595-025-03024-y&rft_id=info%3Apmid%2F40126602&rft.externalDocID=40126602 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0941-1291&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0941-1291&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0941-1291&client=summon |